US Patent 10906971 Monoclonal anti-IL-1RAcP antibodies
Patent 10906971 was granted and assigned to Sanofi on February, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10906971 Monoclonal anti-IL-1RAcP antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.